Company Description

Light Switch Bio are the first to develop photoactivated chemotherapies, a targeted therapy controlled physically by light rather than biologically by molecules. By repurposing toxic systemic drugs into light-targeted pro-drugs, we aim to: avoid their costly off-target toxicities for patients, simplify care continuums for physicians, and revive the value of toxic drugs with de-risked pipelines for developers.